drugset / Trial / NCT00532766

Evaluating Pharmacokinetics and Pharmacodynamics of Jusline

NCT00532766

Completed 20 enrolled King Saud University
RandomizedCrossoverTriple-blindTreatment

Summary

To evaluate the pharmacokinetic and pharmacodynamic profile of a new human insulin (Jusline) after subcutaneous administration, and to compare this profile with Humulin insulin.

Timeline

Start
2006-11
Primary completion
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Protein / enzyme biologic Subcutaneous

Indications

No indication recorded.